Combination of diffusion-weighted magnetic resonance imaging and extended prostate biopsy predicts lobes without significant cancer: Application in patient selection for hemiablative focal therapy

European Urology

Volumn 65, Issue 1, 2014, Pages 186-192

  Matsuoka, Yoh ^a   Numao, Noboru ^a   Saito, Kazutaka ^a   Tanaka, Hiroshi ^b   Kumagai, Jiro ^a   Yoshida, Soichiro ^a   Koga, Fumitaka ^a   Masuda, Hitoshi ^a   Kawakami, Satoru ^a   Fujii, Yasuhisa ^a   Kihara, Kazunori ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b Ochanomizu Surugadai Clinic   (Japan)

Author keywords

Diffusion weighted imaging; Hemiablative focal therapy; Magnetic resonance imaging; Prostate biopsy; Prostate cancer; Radical prostatectomy; Significant cancer

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ABLATION THERAPY; ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER SIZE; CANCER THERAPY; DIFFUSION WEIGHTED IMAGING; DIGITAL RECTAL EXAMINATION; ECHO PLANAR IMAGING; GLEASON SCORE; HEMIABLATIVE FOCAL THERAPY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PATIENT SELECTION; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE VOLUME; PROSTATECTOMY; TRANSRECTAL ULTRASONOGRAPHY; MIDDLE AGED; NEEDLE BIOPSY; PATHOLOGY; PROCEDURES; PROSTATE; PROSTATIC NEOPLASMS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PROSTATE; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 84888846937     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2012.10.010     Document Type: Article

References (30)

1. H.U. Ahmed, D. Pendse, R. Illing, C. Allen, J.H. van der Meulen, and M. Emberton Will focal therapy become a standard of care for men with localized prostate cancer? Nat Clin Pract Oncol 4 2007 632 642
2. S. Eggener, G. Salomon, P.T. Scardino, J. de la Rosette, T.J. Polascik, and S. Brewster Focal therapy for prostate cancer: possibilities and limitations Eur Urol 58 2010 57 64
3. B. Tareen, A. Sankin, G. Godoy, S. Temkin, H. Lepor, and S.S. Taneja Appropriate candidates for hemiablative focal therapy are infrequently encountered among men selected for radical prostatectomy in contemporary cohort Urology 73 2009 351 354 discussion 354-5
4. A.M. Wise, T.A. Stamey, J.E. McNeal, and J.L. Clayton Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens Urology 60 2002 264 269
5. M. Noguchi, T.A. Stamey, J.E. McNeal, and R. Nolley Prognostic factors for multifocal prostate cancer in radical prostatectomy specimens: lack of significance of secondary cancers J Urol 170 2003 459 463
6. M. Karavitakis, M. Winkler, P. Abel, N. Livni, I. Beckley, and H.U. Ahmed Histological characteristics of the index lesion in whole-mount radical prostatectomy specimens: implications for focal therapy Prostate Cancer Prostatic Dis 14 2011 46 52
7. S.R. Bott, H.U. Ahmed, R.G. Hindley, A. Abdul-Rahman, A. Freeman, and M. Emberton The index lesion and focal therapy: an analysis of the pathological characteristics of prostate cancer BJU Int 106 2010 1607 1611
8. B. Turkbey, P.A. Pinto, and P.L. Choyke Imaging techniques for prostate cancer: implications for focal therapy Nat Rev Urol 6 2009 191 203
9. G. Giannarini, G. Petralia, and H.C. Thoeny Potential and limitations of diffusion-weighted magnetic resonance imaging in kidney, prostate, and bladder cancer including pelvic lymph node staging: a critical analysis of the literature Eur Urol 61 2012 326 340
10. C.A. Woodfield, G.A. Tung, D.J. Grand, J.A. Pezzullo, J.T. Machan, and J.F.I.I. Renzulli Diffusion-weighted MRI of peripheral zone prostate cancer: comparison of tumor apparent diffusion coefficient with Gleason score and percentage of tumor on core biopsy Am J Roentgenol 194 2010 W316 W322
11. S. Kawakami, N. Hyochi, and J. Yonese Three-dimensional combination of transrectal and transperineal biopsies for efficient detection of stage T1c prostate cancer Int J Clin Oncol 11 2006 127 132
12. S. Kawakami, N. Numao, and Y. Okubo Development, validation, and head-to-head comparison of logistic regression-based nomograms and artificial neural network models predicting prostate cancer on initial extended biopsy Eur Urol 54 2008 601 611
13. H. Li, K. Sugimura, and Y. Kaji Conventional MRI capabilities in the diagnosis of prostate cancer in the transition zone Am J Roentgenol 186 2006 729 742
14. J.I. Epstein, W.C. Allsbrook Jr., M.B. Amin, and L.L. Egevad The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma Am J Surg Pathol 29 2005 1228 1242
15. J.R. Srigley, M.B. Amin, and J.I. Epstein Updated protocol for the examination of specimens from patients with carcinomas of the prostate gland Arch Pathol Lab Med 130 2006 936 946
16. M. Tsivian, M. Kimura, L. Sun, V. Mouraviev, J.M. Mayes, and T.J. Polascik Predicting unilateral prostate cancer on routine diagnostic biopsy: sextant vs extended BJU Int 105 2010 1089 1092
17. T.J. Polascik, J.M. Mayes, and F.R. Schroeck Patient selection for hemiablative focal therapy of prostate cancer: variables predictive of tumor unilaterality based upon radical prostatectomy Cancer 115 2009 2104 2110
18. K. Eichler, S. Hempel, J. Wilby, L. Myers, L.M. Bachmann, and J. Kleijnen Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review J Urol 175 2006 1605 1612
19. B. Tareen, G. Godoy, A. Sankin, S. Temkin, H. Lepor, and S.S. Taneja Can contemporary transrectal prostate biopsy accurately select candidates for hemi-ablative focal therapy of prostate cancer? BJU Int 104 2009 195 199
20. A. Gallina, C. Maccagnano, and N. Suardi Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy BJU Int 110 2012 E64 E68
21. D.M. Koh, and D.J. Collins Diffusion-weighted MRI in the body: applications and challenges in oncology Am J Roentgenol 188 2007 1622 1635
22. S.L. Giles, V.A. Morgan, S.F. Riches, K. Thomas, C. Parker, and N.M. deSouza Apparent diffusion coefficient as a predictive biomarker of prostate cancer progression: value of fast and slow diffusion components Am J Roentgenol 196 2011 586 591
23. S. Ikonen, P. Karkkainen, and L. Kivisaari Magnetic resonance imaging of clinically localized prostatic cancer J Urol 159 1998 915 919
24. A. Oto, C. Yang, and A. Kayhan Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis Am J Roentgenol 197 2011 1382 1390
25. N. Numao, S. Kawakami, and M. Sakura Characteristics and clinical significance of prostate cancers missed by initial transrectal 12-core biopsy BJU Int 109 2012 665 671
26. A.S. Moussa, A. Meshref, and L. Schoenfield Importance of additional "extreme" anterior apical needle biopsies in the initial detection of prostate cancer Urology 75 2010 1034 1039
27. H.U. Ahmed, Y. Hu, and T. Carter Characterizing clinically significant prostate cancer using template prostate mapping biopsy J Urol 186 2011 458 464
28. J.I. Epstein An update of the Gleason grading system J Urol 183 2010 433 440
29. G. Ploussard, J.I. Epstein, and R. Montironi The contemporary concept of significant versus insignificant prostate cancer Eur Urol 60 2011 291 303
30. B. Helpap, and L. Egevad The significance of modified Gleason grading of prostatic carcinoma in biopsy and radical prostatectomy specimens Virchows Arch 449 2006 622 627